Total Lymphoid Irradiation–Antithymocyte Globulin Conditioning and Allogeneic Transplantation for Patients with Myelodysplastic Syndromes and Myeloproliferative Neoplasms
作者: Jonathan BenjaminSaurabh ChhabraHolbrook E. KohrtPhilip LavoriGinna G. LaportSally AraiLaura JohnstonDavid B. MiklosJudith A. ShizuruWen-Kai WengRobert S. NegrinRobert Lowsky
作者单位: 1Division of Blood and Marrow Transplantation, Stanford University, Stanford, California
2Division of Oncology, Stanford University, Stanford, California
3Department of Health Research and Policy, Stanford University, Stanford, California
刊名: Biology of Blood and Marrow Transplantation, 2014, Vol.20 (6), pp.837-843
来源数据库: Elsevier Journal
DOI: 10.1016/j.bbmt.2014.02.023
关键词: Myelodysplastic syndromeMyeloproliferative neoplasmNonmyeloablative conditioning
原始语种摘要: Abstract(#br)Allogeneic hematopoietic cell transplantation (allo HCT) is the only curative therapy for the myelodysplastic syndromes (MDS) and myeloproliferative neoplasms (MPN), but treatment toxicity has been a barrier to its more widespread use. The nonmyeloablative regimen of total lymphoid irradiation (TLI) and antithymocyte globulin (ATG) permits the establishment of donor hematopoiesis necessary for the graft-versus-malignancy effect and is protective against acute graft-versus-host disease (aGVHD), but it has minimal direct cytotoxicity against myeloid diseases. We explored the use of TLI-ATG conditioning to treat 61 patients with allo HCT for MDS (n = 32), therapy-related myeloid neoplasms (n = 15), MPN (n = 9), and chronic myelomonocytic leukemia (n = 5). The median age of all...
全文获取路径: Elsevier  (合作)
分享到:
来源刊物:
影响因子:3.94 (2012)

×